Reply to Letter to the Editor: Can Differences in Non-Vitamin KAntagonist Oral Anticoagulant Preferences Result in Varying Clinical Outcomes in Patients with Atrial Fibrillation?

Unlu, SerkanAltay, ServetGedikli, OmerOzden, OzgeCanpolat, UgurAskin, LutfuYayla, Cagri2024-06-122024-06-1220242149-22632149-2271https://doi.org/10.14744/AnatolJCardiol.2023.4097https://hdl.handle.net/20.500.14551/25956[Abstract Not Available]en10.14744/AnatolJCardiol.2023.4097info:eu-repo/semantics/openAccess[No Keywords]Reply to Letter to the Editor: Can Differences in Non-Vitamin KAntagonist Oral Anticoagulant Preferences Result in Varying Clinical Outcomes in Patients with Atrial Fibrillation?Letter2817070N/AWOS:0011797721000062-s2.0-8518157470238167800Q3